Laura M. Ferrari

Udine, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine-Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis.

Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine-Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis.

Journal: The oncologist

Published: July 23, 2018

Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic Chemotherapy.

Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic Chemotherapy.

Journal: The oncologist

Published: February 17, 2018

Bone metastases in biliary cancers: A multicenter retrospective survey.

Bone metastases in biliary cancers: A multicenter retrospective survey.

Journal: Journal of bone oncology

Published: August 19, 2017

Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic Chemotherapy.

Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic Chemotherapy.

Journal: The oncologist

Published: April 08, 2017

Efficacy of FOLFOXIRI plus bevacizumab in liver-limited metastatic colorectal cancer: A pooled analysis of clinical studies by Gruppo Oncologico del Nord Ovest.

Efficacy of FOLFOXIRI plus bevacizumab in liver-limited metastatic colorectal cancer: A pooled analysis of clinical studies by Gruppo Oncologico del Nord Ovest.

Journal: European journal of cancer (Oxford, England : 1990)

Published: July 15, 2016

Ramucirumab for the treatment of gastric cancers, colorectal adenocarcinomas, and other gastrointestinal malignancies.

Ramucirumab for the treatment of gastric cancers, colorectal adenocarcinomas, and other gastrointestinal malignancies.

Journal: Expert review of clinical pharmacology

Published: May 06, 2016

Clinico-pathological nomogram for predicting BRAF mutational status of metastatic colorectal cancer.

Clinico-pathological nomogram for predicting BRAF mutational status of metastatic colorectal cancer.

Journal: British journal of cancer

Published: July 26, 2015

Timing and extent of response in colorectal cancer: critical review of current data and implication for future trials.

Timing and extent of response in colorectal cancer: critical review of current data and implication for future trials.

Journal: Oncotarget

Published: April 14, 2015

Angiogenic inhibitors in gastric cancers and gastroesophageal junction carcinomas: A critical insight.

Angiogenic inhibitors in gastric cancers and gastroesophageal junction carcinomas: A critical insight.

Journal: Critical reviews in oncology/hematology

Published: July 16, 2014

Reversible bilateral blepharoptosis following oxaliplatin infusion: a case report and literature review.

Reversible bilateral blepharoptosis following oxaliplatin infusion: a case report and literature review.

Journal: Tumori

Published: February 08, 2014

Evidence-based appraisal of the upfront treatment for unresectable metastatic colorectal cancer patients.

Evidence-based appraisal of the upfront treatment for unresectable metastatic colorectal cancer patients.

Journal: World journal of gastroenterology

Published: September 18, 2013

Angiogenic inhibitors for older patients with advanced colorectal cancer: does the age hold the stage?

Angiogenic inhibitors for older patients with advanced colorectal cancer: does the age hold the stage?

Journal: World journal of gastroenterology

Published: March 09, 2013

Showing 1-12 of 15

Last Updated: 09/26/2026